Skip to main content
OpenTrials

Clinical trial condition

B-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

62 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

B-cell Acute Lymphoblastic Leukemia trial results

Recruiting

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

NCT07570173

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Rigshospitalet ( Site 0802) Copenhagen, Capital Region, Denmark
  • Aarhus Universitetshospital. Hæmatologisk afdeling ( Site 0804) Aarhus Nord, Central Jutland, Denmark
  • Odense Universitetshospital ( Site 0801) Odense, Region Syddanmark, Denmark
  • Rambam Health Care Campus ( Site 0903) Haifa, Israel
View Trial Details
Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
Locations
  • Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
  • Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
View all 71 locations
View Trial Details
Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 54 locations
View Trial Details
Recruiting

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

NCT07223021

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cincinnati Children's Hospital Medical Center (Data Collection Only) Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia (Data Collection Only) Philadelphia, Pennsylvania, United States
  • Baylor College Medical Center (Data Collection Only) Houston, Texas, United States
View Trial Details
Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735

Conditions
B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
View Trial Details

Related conditions